.Adjustments to Financial Statements
Difficulty: Advanced
Adjustments to Current Assets
Eli Lilly & Co., adjusted current assets
USD $ in thousands
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| | Current assets | |||||
| Adjustments | ||||||
| | Add: Allowances for doubtful accounts | |||||
| | Add: LIFO reserve1 | |||||
| After Adjustment | ||||||
| | Adjusted current assets | |||||
Source: Based on data from Eli Lilly & Co. Annual Reports
1 LIFO reserve. See Details »
Adjustments to Total Assets
Eli Lilly & Co., adjusted total assets
USD $ in thousands
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| | Total assets | |||||
| Adjustments | ||||||
| | Add: Operating leased assets1 | |||||
| | Add: Allowances for doubtful accounts | |||||
| | Add: LIFO reserve2 | |||||
| After Adjustment | ||||||
| | Adjusted total assets | |||||
Source: Based on data from Eli Lilly & Co. Annual Reports
1 Operating leased assets. See Details »
2 LIFO reserve. See Details »
Adjustments to Current Liabilities
Eli Lilly & Co., adjusted current liabilities
USD $ in thousands
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| | Current liabilities | |||||
| Adjustments | ||||||
| | Less: Deferred income taxes1 | |||||
| After Adjustment | ||||||
| | Adjusted current liabilities | |||||
Source: Based on data from Eli Lilly & Co. Annual Reports
1 Deferred income taxes. See Details »
Adjustments to Total Liabilities
Eli Lilly & Co., adjusted total liabilities
USD $ in thousands
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| | Total liabilities | |||||
| Adjustments | ||||||
| | Add: Operating lease obligations1 | |||||
| | Less: Deferred income taxes2 | |||||
| After Adjustment | ||||||
| | Adjusted total liabilities | |||||
Source: Based on data from Eli Lilly & Co. Annual Reports
1 Operating lease obligations. See Details »
2 Deferred income taxes. See Details »
Adjustments to Stockholders' Equity
Eli Lilly & Co., adjusted total equity
USD $ in thousands
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| | Total Eli Lilly and Company shareholders' equity | |||||
| Adjustments | ||||||
| | Less: Deferred tax assets (liabilities), net1 | |||||
| | Add: Allowances for doubtful accounts | |||||
| | Add: LIFO reserve2 | |||||
| | Add: Noncontrolling interests | |||||
| After Adjustment | ||||||
| | Adjusted total equity | |||||
Source: Based on data from Eli Lilly & Co. Annual Reports
1 Deferred tax assets (liabilities), net. See Details »
2 LIFO reserve. See Details »
Adjustments to Capitalization Table
Eli Lilly & Co., adjusted capitalization table
USD $ in thousands
| Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | ||
|---|---|---|---|---|---|---|
| As Reported | ||||||
| | Short-term borrowings and current maturities of long-term debt | |||||
| | Long-term debt, excluding current maturities | |||||
| | Total reported debt | |||||
| | Total Eli Lilly and Company shareholders' equity | |||||
| | Total reported capital | |||||
| Adjustments to Debt | ||||||
| | Add: Operating lease obligations1 | |||||
| | Adjusted total debt | |||||
| Adjustments to Equity | ||||||
| | Less: Deferred tax assets (liabilities), net2 | |||||
| | Add: Allowances for doubtful accounts | |||||
| | Add: LIFO reserve3 | |||||
| | Add: Noncontrolling interests | |||||
| | Adjusted total equity | |||||
| After Adjustment | ||||||
| | Adjusted total capital | |||||
Source: Based on data from Eli Lilly & Co. Annual Reports
1 Operating lease obligations. See Details »
2 Deferred tax assets (liabilities), net. See Details »
3 LIFO reserve. See Details »
Adjustments to Reported Income
Eli Lilly & Co., adjusted comprehensive income (loss)
USD $ in thousands
| 12 months ended | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | |
|---|---|---|---|---|---|---|
| As Reported | ||||||
| | Net income (loss) | |||||
| Adjustments | ||||||
| | Add: Deferred income tax expense (benefit)1 | |||||
| | Add: Increase (decrease) in allowances for doubtful accounts | |||||
| | Add: Increase (decrease) in LIFO reserve2 | |||||
| | Add: Other comprehensive income (loss) | |||||
| After Adjustment | ||||||
| | Adjusted comprehensive income (loss) | |||||
Source: Based on data from Eli Lilly & Co. Annual Reports
1 Deferred income tax expense (benefit). See Details »
2 Increase (decrease) in LIFO reserve. See Details »
